Insight

Neville Sanjana: Excited for the potential of RNA-targeting CRISPR platform in health and disease

Neville Sanjana/LinkedIn

Nov 17, 2024, 07:21

Neville Sanjana: Excited for the potential of RNA-targeting CRISPR platform in health and disease

Neville Sanjana, Core Faculty Member at New York Genome Center & Associate Professor of Biology at NYU, shared a post by Cell by Cell Press on LinkedIn, adding the following:

“New study from our group using RNA-targeting CRISPRs and massively-parallel screens to identify functional noncoding RNAs. The function of the vast majority of noncoding RNAs is unknown and we look forward to applying this approach to understand their roles in health and disease. Very excited for the potential of this platform in many new directions!”

Quoting Cell by Cell Press:

“Now online! Transcriptome-scale RNA-targeting CRISPR screens reveal essential lncRNAs in human cells.”

Transcriptome-scale RNA-targeting CRISPR screens reveal essential lncRNAs in human cells

Authors: Wen-Wei Liang, Simon Müller, Sydney K. Hart, Hans-Hermann Wessels, Alejandro Méndez-Mancilla, Akash Sookdeo, Olivia Choi, Christina M. Caragine, Alba Corman, Lu Lu, Olena Kolumba, Breanna Williams, Neville E. Sanjana

Neville Sanjana: Excited for the potential of RNA-targeting CRISPR platform in health and disease

biology biomedical research cancer Cancer research Cell Biology CRISPR technology CRISPR-screens Functional Genomics genetic research health and disease human cells molecular biology Neville Sanjana noncoding RNAs OncoDaily Oncology RNA function RNA-targeting CRISPR transcriptome

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer